Form CORRESP - Correspondence:
SEC Accession No. 0001213900-20-022900
Filing Date
2020-08-19
Accepted
2020-08-19 16:31:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 5841
2 GRAPHIC image_001.jpg GRAPHIC 3165
  Complete submission text file 0001213900-20-022900.txt   11304
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations